HPV vaccine


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.

HPV vaccine

A vaccine that protects against several types of human papillomavirus infection, specifically those associated with genital warts and cervical cancer.
See also: vaccine
References in periodicals archive ?
Key clinical point: Text message reminders for HPV vaccine completion for those who had already started the series were effective.
The findings do not show what was discussed about the HPV vaccine, but Krieger suspects that the cost of the vaccine may be one topic, since if ranges from $360 to $600 for the three-shot series.
There are two HPV vaccines, Gardasil and Cervarix, available to protect against the types of HPV that cause most cervical cancers.
Data Source: A retrospective review of medical records on 3,297 females, aged 9-26 years, who received the first HPV vaccine dose between June 2006 and June 2008 from an urban, academic, pediatric medical center with multiple primary care and specialty clinics.
A Home Office pathologist said it was the chest cancer which caused Natalie's death and there was no sign that the HPV vaccine was a contributing factor.
The available HPV vaccines protect against only two types of viruses associated with cervical cancer.
For instance, GAVI Alliance aims to immunize about 2 million females in developing regions in 2015 using the HPV vaccines Cervarix and Gardasil, which are being supplied at a low cost by GlaxoSmithKline and Merck.
10] The US Centers for Disease Control and Prevention (CDC) highlighted three areas to be addressed to improve the HPV vaccination coverage: the education of parents, as many do not understand the need for the vaccine or have concerns over its safety; healthcare providers who will be involved in recommending the vaccine--some are less likely to recommend the HPV vaccine than they would other vaccines; and the need to reduce missed opportunities for vaccination during healthcare visits.
1) The HPV vaccine can prevent certain types of cancer.
The new policy statement adds the 9-valent HPV vaccine (Gardasil 9), which is recommended by the Advisory Committee on Immunization Practices and was licensed by the Food and Drug Administration in December 2014 for girls and boys aged 11-12 years.
During the trial, 5,752 women received at least one dose of HPV vaccine or placebo and were included in the total vaccinated cohort; on average, women were 37 years old.
The doctor said the HPV vaccine will provide immunity to both boys and girls.